메뉴 건너뛰기




Volumn 21, Issue 6, 2006, Pages 602-607

Perspectives on dyslipidemia and coronary heart disease in women: An update

Author keywords

Coronary heart disease; Dyslipidemia; Women

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; SIMVASTATIN;

EID: 33750349133     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000245739.47712.0a     Document Type: Review
Times cited : (12)

References (38)
  • 1
    • 27544516104 scopus 로고    scopus 로고
    • World Health Organization. Geneva: World Health Organization
    • World Health Organization. Preventing chronic diseases: a vital investment. World Health Organization Global Report 2005. Geneva: World Health Organization; 2005. This report shows that CHD does not only have a major impact in the developed world, but is emerging as the number one killer of women and men in many developing countries as well.
    • (2005) Preventing Chronic Diseases: A Vital Investment. World Health Organization Global Report 2005
  • 2
    • 27444436322 scopus 로고    scopus 로고
    • State of the art paper: Perspectives on dyslipidemia and coronary heart disease in women
    • Bittner V. State of the art paper: perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol 2005; 46:1628-1635. This is a comprehensive review of sex differences in lipoprotein physiology, the role of dyslipidemia in CHD development among women, and the role of lipid-lowering therapy in CHD prevention among women.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1628-1635
    • Bittner, V.1
  • 3
    • 28344442513 scopus 로고    scopus 로고
    • The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population
    • Okamura T, Hayakawa T, Kadowaki T, et al. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 2006; 184:143-150.
    • (2006) Atherosclerosis , vol.184 , pp. 143-150
    • Okamura, T.1    Hayakawa, T.2    Kadowaki, T.3
  • 4
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case control study
    • Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet 2004; 364:937-952.
    • (2004) Lancet , vol.364 , pp. 937-952
    • Yusuf, S.1    Hawken, S.2    Ôunpuu, S.3
  • 5
    • 33644878001 scopus 로고    scopus 로고
    • Risk factors associated with myocardial infarction in Africa. The INTERHEART Africa Study
    • Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa. The INTERHEART Africa Study. Circulation 2005; 112:3554-3561.
    • (2005) Circulation , vol.112 , pp. 3554-3561
    • Steyn, K.1    Sliwa, K.2    Hawken, S.3
  • 6
    • 27644488742 scopus 로고    scopus 로고
    • Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: The CArdiovascular STudy in the Elderly
    • Mazza A, Tikhonoff V, Schiavon L, Casiglia E. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the Elderly. Intern Med J 2005; 35:604-610.
    • (2005) Intern Med J , vol.35 , pp. 604-610
    • Mazza, A.1    Tikhonoff, V.2    Schiavon, L.3    Casiglia, E.4
  • 7
    • 29344455269 scopus 로고    scopus 로고
    • Low-density lipoprotein cholesterol and mortality in older people
    • Tikhonoff V, Casiglia E, Mazza A, et al. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 2005; 53:2159-2164.
    • (2005) J Am Geriatr Soc , vol.53 , pp. 2159-2164
    • Tikhonoff, V.1    Casiglia, E.2    Mazza, A.3
  • 8
    • 29244482002 scopus 로고    scopus 로고
    • Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants
    • Terry DF, Pencina MJ, Vasan RS, et al. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc 2005; 53:1944-1950. This analysis of the Framingham Heart Study points out the importance of cardiovascular risk factors in middle age not only for longevity, but also for morbidity-free survival into old age. Data such as these may enhance 'buy-in' for risk factor reduction programs among patients who are more concerned with quality than quantity of life.
    • (2005) J Am Geriatr Soc , vol.53 , pp. 1944-1950
    • Terry, D.F.1    Pencina, M.J.2    Vasan, R.S.3
  • 9
    • 33645053280 scopus 로고    scopus 로고
    • Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    • Jungner I, Sniderman AD, Furberg C, et al. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? Am J Cardiol 2006; 97:943-946. The study suggested that LDL particle size does not provide incremental information over LDL particle number in predicting risk of fatal myocardial infarction.
    • (2006) Am J Cardiol , vol.97 , pp. 943-946
    • Jungner, I.1    Sniderman, A.D.2    Furberg, C.3
  • 10
    • 33644861577 scopus 로고    scopus 로고
    • Increased small low-density lipoprotein particle number. A prominent feature of the metabolic syndrome in the Framingham Heart Study
    • Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small low-density lipoprotein particle number. A prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006; 113:20-29. This study confirmed the strong relationship between triglycerides, HDL-cholesterol level and number of small dense LDL particles among patients with metabolic syndrome, but found that the number of small dense LDL particles does not increase risk of cardiovascular events among these patients.
    • (2006) Circulation , vol.113 , pp. 20-29
    • Kathiresan, S.1    Otvos, J.D.2    Sullivan, L.M.3
  • 11
    • 25844457344 scopus 로고    scopus 로고
    • Lipoprotein (a) and coronary heart disease among women: Beyond a cholesterol carrier?
    • Shai I, Rimm EB, Hankinson SE, et al. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? European Heart Journal 2005; 26:1633-1639. This study reported increased cardiovascular risk among women with high lipoprotein (a). Whether treatment of lipoprotein (a) levels could ameliorate this risk is unknown.
    • (2005) European Heart Journal , vol.26 , pp. 1633-1639
    • Shai, I.1    Rimm, E.B.2    Hankinson, S.E.3
  • 12
    • 27844518270 scopus 로고    scopus 로고
    • A prospective study of plasma lipid levels and hypertension in women
    • Sesso HS, Buring JE, Chown MJ, et al. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med 2005; 165:2420-2427. An interesting analysis from the Women's Health Study suggests that dyslipidemia predicts future incidence of hypertension, even among women with normal blood pressures at baseline.
    • (2005) Arch Intern Med , vol.165 , pp. 2420-2427
    • Sesso, H.S.1    Buring, J.E.2    Chown, M.J.3
  • 14
    • 33646270614 scopus 로고    scopus 로고
    • Heart disease risk determines menopausal age rather than the reverse
    • Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47:1976-1983. This provocative analysis of the Framingham dataset suggests that cardiovascular risk factors prior to menopause determine age at menopause.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1976-1983
    • Kok, H.S.1    Van Asselt, K.M.2    Van Der Schouw, Y.T.3
  • 15
    • 33646247178 scopus 로고    scopus 로고
    • Menopause and cardiovascular risk: Cause or consequence?
    • Bittner V. Menopause and cardiovascular risk: cause or consequence? J Am Coll Cardiol 2006; 47:1984-1986.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1984-1986
    • Bittner, V.1
  • 16
    • 33645068471 scopus 로고    scopus 로고
    • Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women
    • Mora S, Lee I-M, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006; 295:1412-1419. This important analysis of the Women's Health Study suggests that a physically active lifestyle cannot counteract the adverse cardiovascular consequences of obesity.
    • (2006) JAMA , vol.295 , pp. 1412-1419
    • Mora, S.1    Lee, I.-M.2    Buring, J.E.3    Ridker, P.M.4
  • 17
    • 32144443648 scopus 로고    scopus 로고
    • Low-fat dietary pattern and risk of cardiovascular disease: The Women's Health Initiative Randomized Controlled Dietary Intervention
    • Howard BV, van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Intervention. JAMA 2006; 295:655-666. The report from the Women's Health Initiative diet trial indicates that the low fat diet designed to prevent colon and breast cancer was not effective in reducing cardiovascular event rates over 8 years of follow-up.
    • (2006) JAMA , vol.295 , pp. 655-666
    • Howard, B.V.1    Van Horn, L.2    Hsia, J.3
  • 18
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
    • The FIELD Study Investigators
    • The FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366:1849-1961. This was the only fibrate trial that included women, but did not meet its primary endpoint. No sex differences were observed.
    • (2005) Lancet , vol.366 , pp. 1849-1961
  • 19
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352:1425-1435. This statin trial suggested enhanced benefits with more aggressive statin therapy.
    • (2005) N Engl J Med , vol.352 , pp. 1425-1435
    • Larosa, J.C.1    Grundy, S.M.2    Waters, D.D.3
  • 20
    • 27744603499 scopus 로고    scopus 로고
    • High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL Study: A Randomized Controlled Trial
    • Pedersen TR, Faergeman O, Kastelein JJP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL Study: A Randomized Controlled Trial. JAMA 2005; 294:2437-2445. This statin trial did not meet its primary endpoint, but largely confirmed the results of the Treating to New Targets Study.
    • (2005) JAMA , vol.294 , pp. 2437-2445
    • Pedersen, T.R.1    Faergeman, O.2    Kastelein, J.J.P.3
  • 21
    • 23044465843 scopus 로고    scopus 로고
    • Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women
    • Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women. Circulation 2005; 112:563-571. The authors describe a trial that compared two intensities of lipid-lowering therapy, achieved a substantial LDL-cholesterol difference between treatment groups, but could not show any difference in change in coronary calcification during follow-up. Electron beam tomography may not be a good surrogate endpoint in short-term lipid-lowering trials.
    • (2005) Circulation , vol.112 , pp. 563-571
    • Raggi, P.1    Davidson, M.2    Callister, T.Q.3
  • 22
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366:1267-1278. The authors conducted a meta-analysis of lipid-lowering trials which indicated that there are no sex differences in efficacy of lipid-lowering therapy.
    • (2005) Lancet , vol.366 , pp. 1267-1278
  • 23
    • 28544449320 scopus 로고    scopus 로고
    • Pregnancy outcomes after maternal exposure to simvastatin and lovastatin
    • Pollack PS, Shields KE, Burnett DM, et al. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Research (Part A) 2005; 73:888-896. This is a unique compilation of data on teratogenic effects of statins.
    • (2005) Birth Defects Research (Part A) , vol.73 , pp. 888-896
    • Pollack, P.S.1    Shields, K.E.2    Burnett, D.M.3
  • 24
    • 33644878723 scopus 로고    scopus 로고
    • Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use
    • Arnett DK, Jacobs DR, Luepker RV, et al. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use. Circulation 2005; 112:3884-3891. This report from the Minnesota Heart Survey shows lack of awareness of hyperlipidemia and inadequate control of dyslipidemia among treated participants.
    • (2005) Circulation , vol.112 , pp. 3884-3891
    • Arnett, D.K.1    Jacobs, D.R.2    Luepker, R.V.3
  • 25
    • 33644851060 scopus 로고    scopus 로고
    • Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Gender, Ethnicity, and Coronary Artery Calcium
    • Goff DC, Bertoni AG, Kramer H, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Gender, Ethnicity, and Coronary Artery Calcium. Circulation 2006; 113:647-656. This study showed substantial heterogeneity in prevalence, treatment, and control of dyslipidemia among different ethnic groups.
    • (2006) Circulation , vol.113 , pp. 647-656
    • Goff, D.C.1    Bertoni, A.G.2    Kramer, H.3
  • 26
    • 18244366340 scopus 로고    scopus 로고
    • Ambulatory hypercholesterolemia management in patients with atherosclerosis
    • Persell SD, Maviglia SM, Bates DW, Ayanian JZ. Ambulatory hypercholesterolemia management in patients with atherosclerosis. J Gen Intern Med 2005; 20:123-130.
    • (2005) J Gen Intern Med , vol.20 , pp. 123-130
    • Persell, S.D.1    Maviglia, S.M.2    Bates, D.W.3    Ayanian, J.Z.4
  • 27
    • 28344446007 scopus 로고    scopus 로고
    • Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene
    • Wenger NK, Geiger MJ. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene. Contemporary Clinical Trials 2005; 26:612-615.
    • (2005) Contemporary Clinical Trials , vol.26 , pp. 612-615
    • Wenger, N.K.1    Geiger, M.J.2
  • 28
    • 27544487525 scopus 로고    scopus 로고
    • Prevalence and control of dyslipidemia among persons with diabetes in the United States
    • Jacobs MJ, Kleisli T, Pio JR, et al. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Research and Clinical Practice 2005; 70:263-269. This report points out poor control of dyslipidemia among US patients with diabetes, a group at particularly high risk for CHD morbidity and mortality.
    • (2005) Diabetes Research and Clinical Practice , vol.70 , pp. 263-269
    • Jacobs, M.J.1    Kleisli, T.2    Pio, J.R.3
  • 29
    • 27444444782 scopus 로고    scopus 로고
    • Women in cardiac rehabilitation: Outcomes and identifying risk for drop-out
    • Sanderson BK, Bittner V. Women in cardiac rehabilitation: outcomes and identifying risk for drop-out. Am Heart J 2005; 150:1052-1058. Attendance at cardiac rehabilitation may improve the proportion of women who achieve Adult Treatment Panel III treatment goals.
    • (2005) Am Heart J , vol.150 , pp. 1052-1058
    • Sanderson, B.K.1    Bittner, V.2
  • 30
    • 27444443241 scopus 로고    scopus 로고
    • Socioeconomic gradient in use of statins among Danish patients: Population-based cross-sectional study
    • Thomsen RW, Johnsen SP, Olesen AV, et al. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 2005; 60:534-542.
    • (2005) Br J Clin Pharmacol , vol.60 , pp. 534-542
    • Thomsen, R.W.1    Johnsen, S.P.2    Olesen, A.V.3
  • 31
    • 23044509719 scopus 로고    scopus 로고
    • Statin use after acute myocardial infarction: A nationwide study in Denmark
    • Rasmussen JN, Gislason GH, Abildstrom SZ, et al. Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 2005; 60:150-158.
    • (2005) Br J Clin Pharmacol , vol.60 , pp. 150-158
    • Rasmussen, J.N.1    Gislason, G.H.2    Abildstrom, S.Z.3
  • 32
    • 27744513624 scopus 로고    scopus 로고
    • WHO study on prevention of recurrences of myocardial infarction and stroke (WHO PREMISE)
    • Mendis S, Abegunde D, Yusuf S, et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO PREMISE). Bulletin of the World Health Organization 2005; 83:820-828. This 10-country survey documents a sex gap in lipid lowering therapy.
    • (2005) Bulletin of the World Health Organization , vol.83 , pp. 820-828
    • Mendis, S.1    Abegunde, D.2    Yusuf, S.3
  • 33
    • 33644869863 scopus 로고    scopus 로고
    • Gender differences in the management and clinical outcome of stable angina
    • on behalf of the Euro Heart Survey Investigators
    • Daly C, Clemens F, Lopez Sendon JL, et al., on behalf of the Euro Heart Survey Investigators. Gender differences in the management and clinical outcome of stable angina. Circulation 2006; 113:490-498. The authors document underutilization of statins among European women with angina.
    • (2006) Circulation , vol.113 , pp. 490-498
    • Daly, C.1    Clemens, F.2    Lopez Sendon, J.L.3
  • 34
    • 31344481878 scopus 로고    scopus 로고
    • Secondary prevention of coronary heart disease in older patients after the national service framework: Population based study
    • Ramsay SE, Whincup PH, Lawlor DA, et al. Secondary prevention of coronary heart disease in older patients after the national service framework: population based study. BMJ 2006; 332:144-145. This shows improvement in treatment rates among older women between 1998 and 2003.
    • (2006) BMJ , vol.332 , pp. 144-145
    • Ramsay, S.E.1    Whincup, P.H.2    Lawlor, D.A.3
  • 35
    • 28444487891 scopus 로고    scopus 로고
    • Compliance with a statin treatment in a usual-care setting: Retrospective database analysis over 3 years after treatment initiation in Health Maintenance Organization enrollees with dyslipidemia
    • Caspard H, Chan AK, Walker AM. Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in Health Maintenance Organization enrollees with dyslipidemia. Clin Ther 2005; 27:1639-1646.
    • (2005) Clin Ther , vol.27 , pp. 1639-1646
    • Caspard, H.1    Chan, A.K.2    Walker, A.M.3
  • 36
    • 29144515723 scopus 로고    scopus 로고
    • Long-term adherence with cardiovascular drug regimens
    • Kulkarni SP, Alexander KP, Lytle B, et al. Long-term adherence with cardiovascular drug regimens. Am Heart J 2006; 151:185-191.
    • (2006) Am Heart J , vol.151 , pp. 185-191
    • Kulkarni, S.P.1    Alexander, K.P.2    Lytle, B.3
  • 37
    • 1042278732 scopus 로고    scopus 로고
    • Tracking women's awareness of heart disease. An American Heart Association National Study
    • Mosca L, Ferris A, Fabunmi R, Robertson M. Tracking women's awareness of heart disease. An American Heart Association National Study. Circulation 2004; 109:573-579.
    • (2004) Circulation , vol.109 , pp. 573-579
    • Mosca, L.1    Ferris, A.2    Fabunmi, R.3    Robertson, M.4
  • 38
    • 13444287861 scopus 로고    scopus 로고
    • National study of physician awareness and adherence to cardiovascular disease prevention guidelines
    • Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111:499-510. A web-based survey of primary care providers, obstetrics/gynecology physicians and cardiologists documents that many providers underestimate CHD risk among women and thus tend to underutilize appropriate risk reduction strategies.
    • (2005) Circulation , vol.111 , pp. 499-510
    • Mosca, L.1    Linfante, A.H.2    Benjamin, E.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.